Colgate-Palmolive Company (CL) Fair Value & Analysis
Consumer Defensive · US · Market cap $73.8B · ISIN US1941621039
What is Colgate-Palmolive Company really worth?
Colgate-Palmolive Company
CL · US
A solid business, but trading 63% above our fair value of $55.28.
Strengths
Risks
For context
Fair value as of: Aug 30, 2026
From 25 valuation models · updated 6 days ago
Share price −2.6% over the past month.
What runs behind every stock
69 individual criteria per stock, every one traceable See the method →
What matters now
- A high-quality business (quality 74/100), yet the market already pays well above fair value. Quality at a full price, with little margin of safety.
- The price sits above even our optimistic bull case ($69.94). The favourable scenario is already priced in.
- A fairly wide model range ($38.14 to $69.94) leaves room in how you read the outcome.
Price vs Fair Value (5 years)
White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Aug 30, 2026.
How to read this chart
60‑month range $62.58 – $104.38 · fair‑value band $38.14 – $69.94 · the $90.09 price screens above the $55.28 fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). Dashed = 300-day average. As of Aug 30, 2026.
Analysis
Colgate-Palmolive Company (CL) currently trades at $90.09, while our model-based Fair Value estimate is $55.28, implying the stock looks roughly 63.0% overvalued today. The Quality Score stands at 74/100 (solid quality), in the Consumer Defensive sector. Bull case: the DCF Models group reads highest at a median of $51.53 per share, and 0 of the 25 models we run sit above the $90.09 price. Bear case: the Dividend Discount group reads lowest at $29.82, and 25 of the 25 models stay below the price. Evidence for this calculation is high.
Over the trailing twelve months, Colgate-Palmolive Company generated revenue of $20.8B at a net margin of 10.0%. Revenue grew 8.4% year over year. It earns a return on equity of 36.4%. Net debt stands at $6.7B. Fundamentals as of Aug 30, 2026
Our scenario range runs from $38.14 (bear case) to $69.94 (bull case); at $90.09, the current price sits above that range. Bear and bull are the same models run on conservative and optimistic assumptions (margins, growth, valuation multiples), so a plausible valuation range, not a price target. The share trades about 9% below its 52-week high and 22% above its 52-week low, currently above its 200-day average. For context, the median of 10 Consumer Defensive peers we cover trades at −28% fair-value upside, at −39%, CL screens richer than that median.
Fair Value models
This estimate rests on fiscal year 2025 figures, and about 8 months have passed since. In that time the company retained roughly $0.3397 per share, which is 0.6 % of the fair value. The fair value deliberately does not add this in: the models value reported figures, not a projection.
Each model estimates fair value its own way; the Fair Value above is the evidence-weighted, family-balanced blend. Evidence (0–100) measures how completely this model’s inputs are available: well-fed models carry more weight in the blend. The spread across models is intentional, each one stresses a different value driver; dividend models, for instance, come out structurally low when payout is small. Every input is real reported data, nothing guessed.
All 25 models by family
Widest divergence: DCF Models ($51.53) versus Asset-Based ($0.3100). Highest evidence: FCF DCF (80).
Notify me when CL reaches fair value
Put CL on your watchlist. We get in touch as soon as price and fair value meet or the trend turns.
Set up alert →Free, no payment details. Unsubscribe anytime in one click.
Key figures & financial health
More key figures
Figures from reported company fundamentals · as of Aug 30, 2026. TTM = trailing twelve months.
Quality Score breakdown
Of which business quality 71 · Market factors (momentum, volatility) 62
Non-valuation factor families (profitability, growth, cashflow, financial strength, momentum …), each academically grounded. Valuation itself sits in the Fair Value and is deliberately excluded here to avoid double-counting.
All values are scores from 0 to 100 (100 = best against fixed, research-based bands), not percentages. The three market factors (momentum, 52-week proximity, low volatility) are displayed but carry zero weight in the headline number: market sentiment is not a business property.
About the company
Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition.
Full company description
Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items. This segment markets and sells its products under the Colgate, Palmolive, Darlie, elmex, hello, meridol, Sorriso, Tom's of Maine, EltaMD, Filorga, Irish Spring, Lady Speed Stick, PCA SKIN, Protex, Sanex, Softsoap, Speed Stick, Ajax, Axion, Fabuloso, Murphy, Soupline, and Suavitel brands to a range of traditional and eCommerce retailers, wholesalers, and distributors, as well as dentists and skin health professionals. It also offers pharmaceutical products for dentists and other oral health professionals. The Pet Nutrition segment offers pet nutrition products for everyday nutritional needs under the Hill's Science Diet brand; and a range of therapeutic pet products to help nutritionally support dogs and cats in different stages of health under the Hill's Prescription Diet brand; and a fresh pet food sold to pet specialty and other retailers in Australia under Prime100 brand. This segment markets and sells its products through pet supply retailers, veterinarians, and eCommerce retailers. Colgate-Palmolive Company was founded in 1806 and is headquartered in New York, New York.
Company description, as reported by the company or data provider.
Revenue & earnings trend
FY2021 – FY2025 · reported fiscal years
Colgate-Palmolive Company reported revenue of $20.4B in FY2025 versus $17.4B in FY2021, a compound +4.0%/yr. Reported net income was $2.1B in FY2025, compounding −0.4%/yr from FY2021.
of which total revenue +2.4 % · buybacks/dilution +1.2 %
Annual growth per factor. These are factors, not summands: multiplied they give the EPS growth rate, added they do not quite. Start and end points are 3-year averages (details on hover).
CL screens 63% overvalued. Compare with L'Oréal S.A →
Recent news
External third-party headlines (Yahoo Finance, Reuters and others), not an editorial selection.
- Colgate-Palmolive Webcasts Fireside Chat at the Barclays 2026 Global Consumer Staples Conference
- Did Colgate-Palmolive’s (CL) Volume-Led Q2 Strength Just Shift Its Investment Narrative?
- Household Products Stocks Q2 Teardown: Colgate-Palmolive (NYSE:CL) Vs The Rest
Peer Group
Household & Personal Products · 244 stocks
How this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.
Valuation Multiples vs Household & Personal Products median · lower = cheaper
Strength profile in five axes (Snowflake)
Five quick dimensions, each 0 to 100: VALUE (fair-value potential), FUTURE (revenue growth), PAST (return on equity), HEALTH (low debt), DIVIDEND (yield). Green = this stock, grey = typical sector peer.
VALUE 0: the price sits above our fair-value range.
Insider activity: 40/100
Values & ESG
Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.
Similar stocks
10 more Household & Personal Products stocks, each showing price versus our Fair Value estimate (as of Aug 30, 2026).
| Stock | Price | Fair Value | vs Fair Value |
|---|---|---|---|
| L'Oréal S.A LORL | C$24.76 | C$22.64 | −9% |
| Unilever PLC UNA | €55.92 | €40.47 | −28% |
| 500696 500696 | ₹2,093 | ₹641.55 | −69% |
| Hindustan Unilever Limited HINDUNILVR | ₹2,015 | ₹789.46 | −61% |
| Kenvue Inc KVUE | $18.95 | $10.97 | −42% |
| Kimberly-Clark Corporation KMB | $109.55 | $79.71 | −27% |
| Henkel AG HEN3 | €75.82 | €85.95 | +13% |
| The Estée Lauder Companies Inc ESLA | €86.54 | €18.84 | −78% |
| Church & Dwight Co CHD | $101.26 | $65.12 | −36% |
| Beiersdorf Aktiengesellschaft, BEI | €80.42 | €68.36 | −15% |
Compare Colgate-Palmolive Company with another stock
Price, fair value, quality and upside side by side.
Explore undervalued stocks
More undervalued Consumer Defensive stocks →
Try a ready-made strategy
Pick a strategy and jump into the live analysis with that exact screen applied.
Discover tools
Frequently asked questions
Is Colgate-Palmolive Company (CL) overvalued or undervalued?
What is the fair value of CL?
What is the quality score of CL?
What is the revenue of Colgate-Palmolive Company (CL)?
What is the net profit margin of CL?
Does Colgate-Palmolive Company pay a dividend?
Watch Colgate-Palmolive Company in the live analysis
One click puts Colgate-Palmolive Company on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 35,000+ stock screener. You can also try 14 days of Pro there, no card.
Watch for free →Zero risk: nothing is ever charged. Your watchlist is yours, with or without an account.